Ariad has posted a new investor overview video. The one thing of interest is Bergers discussion of the company's ponatinib partnering plans (begins at around the 2 minute mark). In a nutshell, the company plans to partner regionally outside the US in order to "take advantage of the strength of partners in those markets as well as the added financial resources that that can bring to help us develop our overall pipeline of products."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.